Results 231 to 240 of about 707,954 (344)
Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi +13 morewiley +1 more sourceSNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez +18 morewiley +1 more sourcePrediction Model for Etiologic Differentiation of Isolated Vestibular Syndrome in Emergency Settings
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods
In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation (n = 301) and validation (n = 205)Guo Wenting, Du Liping, Yang Yi, Hu Jin, Ye Bijun, Wang Jianer, Liu Shuangsi, Guo Shunyuan, Cai Xiaofeng, Wang Huiyuan, Wu Bin, Yu Xiang, Shi Tianming +12 morewiley +1 more sourceEveryday norms have become more permissive over time and vary across cultures. [PDF]
Commun PsycholEriksson K, Strimling P, Vartanova I, Simpson B, Persson M, Abdi KA, Ad N, Aldashev A, Ali HM, Alì M, Aliyev K, Alrefaee YMHA, Alvarado Ortiz AE, Andersson PA, Andrighetto G, Arikan G, Aruta JJBR, Ayikwa CL, Baños-Chaparro J, Barrera D, Barsyte J, Batkeyev B, Batool A, Berezina E, Bimina SN, Björnstjerna M, Blumen S, Boski P, Boštjančič E, Boum Y, Briguglio M, Bruno K, Bui HTT, Caycho-Rodríguez T, Chen Y, Chiweshe MK, Choi HS, Contreras-Ibáñez CC, Čorkalo D, Cruz-Torres CE, Czakó A, de Zoysa P, Demetrovics Z, Dinić BM, Drače S, El-Haddad RW, Engelmann JB, Escudero Pérez I, Euh H, Fang X, Frank C, Freidin E, Fulop M, Gamsakhurdia V, García Jiménez MA, Gardarsdottir RB, Gavreliuc A, Gill CMHD, Gjoneska B, Glöckner A, Graf S, Grigoryan A, Growiec K, Haas BW, Haddock G, Hadjisolomou SP, Hadžiahmetović N, Haji Mohammad Ali MH, Hakoköngäs E, Halama P, Hapunda G, Hartanto A, Hazrati M, Herbas-Torrico BC, Holka S, Hřebíčková M, Hunter JA, Ibikounle M, Ilisko D, Lind Hjördísar Jónsdóttir H, Kaminskiene Z, Kapoor H, Kapović I, Karim G, Kawakami K, Khachatryan N, Kirschner JB, Kiruja J, Kiyonari T, Kohút M, Kousar S, Krasniqi B, Lado L, Landa-Blanco M, Landon B, Lep Ž, Leslie LM, Li Y, Liik K, Lin MJ, Lobos Rivera ME, López-López W, Maloku E, Mandal M, Manhique BA, Mbende NM, Medhioub I, Teixeira MLM, Merchán Tamayo JP, Mohammed LL, Moore SN, Moraligil B, Muradzada N, Nanda H, Nastina E, Nejat P, Nettle D, Nipassa OJA, Noe-Grijalva M, Ntampaka P, Ntone R, Nussinson R, Oljača M, Onyedire NG, Onyishi IE, Panagiotopoulou P, Alvarez DP, Parvez MS, Pasin GL, Pedović I, Pérez de León P, Perez Floriano LR, Pop-Jordanova N, Portillo JR, Potang A, Quesada-Román A, Raver JL, Rodrigues RB, Rodríguez-Romero JD, Romanò S, Ross RM, Rosun N, Sadiković S, San Martin A, Smederevac S, Smith SJ, Soboleva N, Sonessa DE, Stanley SK, Stoyanova K, Stoyanov D, Takemura K, Thøgersen J, Tiliouine H, Tung H, Ulambayar T, Uzdavinyte EM, Waechter R, Wang YT, Wu J, Yambio BM, Yankson E, Yeh KH, Van Lange PAM. +163 moreeuropepmc +1 more sourceCSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction
Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan +12 morewiley +1 more source